共 50 条
Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatments
被引:51
|作者:
Singh, Meenu
[1
]
Rebordosa, Cristina
[2
]
Bernholz, Juliane
[3
]
Sharma, Neeraj
[4
]
机构:
[1] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India
[2] Novartis Farmaceut SA, Dept Epidemiol, Div Drug Safety & Epidemiol, Barcelona, Spain
[3] Novartis Pharma AG, Dept Dev, Div Pharma, Basel, Switzerland
[4] Johns Hopkins Univ, Sch Med, Dept Pediat, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
来源:
关键词:
CFTR;
cystic fibrosis;
epidemiology;
genetics;
potentiator;
CFTR GENE;
IRANIAN PATIENTS;
INDIAN PATIENTS;
1ST REPORT;
MUTATIONS;
IDENTIFICATION;
CHILDREN;
PROFILE;
POPULATION;
FREQUENCY;
D O I:
10.1111/resp.12656
中图分类号:
R56 [呼吸系及胸部疾病];
学科分类号:
摘要:
Cystic fibrosis (CF) in the Asian population is less frequently reported due to under-diagnosis and lack of centralized CF patient registries. Clinical studies on CF cases from Asia have documented a severe course of the disease. The spectrum of the cystic fibrosis transmembrane conductance regulator (CFTR) variants in this population is quite heterogeneous. In total, 166 variants have been reported on approximately 3700 Asian CF chromosomes. The frequency of F508del among Asians is low compared with Caucasians. Recent in vitro studies have shown promise of small molecule correction and potentiation of 45 different CFTR variants. Of these variants, 16 (including G551D and F508del) have also been observed among Asian CF individuals. We suggest undertaking molecular studies extensively to annotate CFTR variants that will help Asian CF individuals to benefit from the precision medicine gaining momentum in the Western countries.
引用
收藏
页码:1172 / 1181
页数:10
相关论文